OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 4, pp. 386-394
Closed Access | Times Cited: 23
Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 4, pp. 386-394
Closed Access | Times Cited: 23
Showing 23 citing articles:
The epidemiology of Chagas disease in the Americas
Zulma M. Cucunubá, Sebastián A Gutiérrez-Romero, Juan David Ramírez, et al.
The Lancet Regional Health - Americas (2024) Vol. 37, pp. 100881-100881
Open Access | Times Cited: 12
Zulma M. Cucunubá, Sebastián A Gutiérrez-Romero, Juan David Ramírez, et al.
The Lancet Regional Health - Americas (2024) Vol. 37, pp. 100881-100881
Open Access | Times Cited: 12
Tackling the Challenges of human Chagas Disease: a Comprehensive Review of Treatment Strategies in the Chronic Phase and Emerging Therapeutic Approaches
Laís G. Ramos, Kátia R. de Souza, Policarpo Ademar Sales, et al.
Acta Tropica (2024) Vol. 256, pp. 107264-107264
Closed Access | Times Cited: 10
Laís G. Ramos, Kátia R. de Souza, Policarpo Ademar Sales, et al.
Acta Tropica (2024) Vol. 256, pp. 107264-107264
Closed Access | Times Cited: 10
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 575-590
Closed Access | Times Cited: 7
Fernanda Karoline Vieira da Silva Torchelsen, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 575-590
Closed Access | Times Cited: 7
New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi , the causative agent of Chagas disease
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 6
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 6
Cardiac involvement in Chagas disease and African trypanosomiasis
Éster Cerdeira Sabino, Maria Carmo Pereira Nunes, Johannes Blum, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 12, pp. 865-879
Closed Access | Times Cited: 6
Éster Cerdeira Sabino, Maria Carmo Pereira Nunes, Johannes Blum, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 12, pp. 865-879
Closed Access | Times Cited: 6
Challenges and advancements in the development of vaccines and therapies against Chagas disease
María‐Jesús Pinazo, Emilio L. Malchiodi, Jean‐Robert Ioset, et al.
The Lancet Microbe (2024), pp. 100972-100972
Open Access | Times Cited: 5
María‐Jesús Pinazo, Emilio L. Malchiodi, Jean‐Robert Ioset, et al.
The Lancet Microbe (2024), pp. 100972-100972
Open Access | Times Cited: 5
Utility of Magnetic Bead-Based Automated DNA Extraction to Improve Chagas Disease Molecular Diagnosis
Priscila Silva Grijó Farani, Jacqueline Lopez, Amanda Faier-Pereira, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 937-937
Open Access
Priscila Silva Grijó Farani, Jacqueline Lopez, Amanda Faier-Pereira, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 937-937
Open Access
HIV and Chagas disease coinfection
Jesús Fernández Plaza, Javier Guzmán, Sandra Chamorro-Tojeiro, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2025) Vol. 43, Iss. 2, pp. 117-119
Closed Access
Jesús Fernández Plaza, Javier Guzmán, Sandra Chamorro-Tojeiro, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2025) Vol. 43, Iss. 2, pp. 117-119
Closed Access
3D printing as a solution for tablet splitting challenges dedicated to the Chagas disease treatment
Giselle Bedogni, Ana Luiza Lima, Idejan P. Gross, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106745-106745
Closed Access
Giselle Bedogni, Ana Luiza Lima, Idejan P. Gross, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106745-106745
Closed Access
Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population
Yolanda Hernández, María Elena Marsón, Marisa Fernández, et al.
Memórias do Instituto Oswaldo Cruz (2025) Vol. 120
Open Access
Yolanda Hernández, María Elena Marsón, Marisa Fernández, et al.
Memórias do Instituto Oswaldo Cruz (2025) Vol. 120
Open Access
Atomistic Insights into gp82 Binding: A Microsecond, Million-Atom Exploration of Trypanosoma cruzi Host-Cell Invasion
Ricardo de Souza Rosa, Manuela Leal da Silva, Rafael C. Bernardi
Biochemistry (2025)
Closed Access
Ricardo de Souza Rosa, Manuela Leal da Silva, Rafael C. Bernardi
Biochemistry (2025)
Closed Access
The Chagas non-endemic (ChaNoE) cohort: Aims and study protocol
Pau Bosch‐Nicolau, Juan María Herrero‐Martínez, Marta Arsuaga, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320637-e0320637
Open Access
Pau Bosch‐Nicolau, Juan María Herrero‐Martínez, Marta Arsuaga, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320637-e0320637
Open Access
Shorter treatment in chronic Chagas disease: a new promise?
Reinaldo B. Bestetti, Edimar Alcides Bocchi
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 4, pp. 333-334
Closed Access | Times Cited: 3
Reinaldo B. Bestetti, Edimar Alcides Bocchi
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 4, pp. 333-334
Closed Access | Times Cited: 3
Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience
M. Budel, Ana Paula Alegretti, Natália P. Prado, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 5
Closed Access | Times Cited: 3
M. Budel, Ana Paula Alegretti, Natália P. Prado, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 5
Closed Access | Times Cited: 3
Treatments and the Perspectives of Developing a Vaccine for Chagas Disease
Priscila Silva Grijó Farani, Kathryn M. Jones, Cristina Poveda
Vaccines (2024) Vol. 12, Iss. 8, pp. 870-870
Open Access | Times Cited: 3
Priscila Silva Grijó Farani, Kathryn M. Jones, Cristina Poveda
Vaccines (2024) Vol. 12, Iss. 8, pp. 870-870
Open Access | Times Cited: 3
Oral Chagas disease outbreak by bacaba juice ingestion: A century after Carlos Chagas’ discovery, the disease is still hard to manage
Eudes Alves Simões Neto, Daniel Wagner de Castro Lima Santos, Maria Rosa Quaresma Bomfim, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 9, pp. e0012225-e0012225
Open Access | Times Cited: 2
Eudes Alves Simões Neto, Daniel Wagner de Castro Lima Santos, Maria Rosa Quaresma Bomfim, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 9, pp. e0012225-e0012225
Open Access | Times Cited: 2
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Synthesis and Anti-Trypanosoma cruzi Activity of New Pyrazole-Thiadiazole Scaffolds
Thamyris Perez de Souza, Lorraine Martins Rocha Orlando, Leonardo da Silva Lara, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3544-3544
Open Access | Times Cited: 1
Thamyris Perez de Souza, Lorraine Martins Rocha Orlando, Leonardo da Silva Lara, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3544-3544
Open Access | Times Cited: 1
Obtención y evaluación preclínica de nanovehículos farmacéuticos con aplicación en el tratamiento de la enfermedad de Chagas
Giuliana Muraca
(2024)
Open Access
Giuliana Muraca
(2024)
Open Access
Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories
Laurène Cachera, Erwan Oehler, Karim Abdelmoumen, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 6
Closed Access
Laurène Cachera, Erwan Oehler, Karim Abdelmoumen, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 6
Closed Access
Atomistic Insights into gp82 Binding: A Microsecond, Million-Atom Exploration of Trypanosoma cruzi Host-Cell Invasion
Ricardo de Souza Rosa, Manuela Leal da Silva, Rafael C. Bernardi
(2024)
Closed Access
Ricardo de Souza Rosa, Manuela Leal da Silva, Rafael C. Bernardi
(2024)
Closed Access
Enfermedad de Chagas y coinfección por el VIH
Jesús Fernández Plaza, Javier Guzmán, Sandra Chamorro-Tojeiro, et al.
Enfermedades Infecciosas y Microbiología Clínica (2024)
Closed Access
Jesús Fernández Plaza, Javier Guzmán, Sandra Chamorro-Tojeiro, et al.
Enfermedades Infecciosas y Microbiología Clínica (2024)
Closed Access
Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis
Anis Rassi, Alyssa Grimshaw, Aarti Sarwal, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102972-102972
Open Access
Anis Rassi, Alyssa Grimshaw, Aarti Sarwal, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102972-102972
Open Access
